Back
Xencor 10K Form
Sell
49
XNCR
Xencor
Last Price:
$11.28
Seasonality Move:
13.21%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | XNCR/Xencor Quarterly |
| 2023-11-08 | 10Q | XNCR/Xencor Quarterly |
| 2023-08-03 | 10Q | XNCR/Xencor Quarterly |
| 2023-05-08 | 10Q | XNCR/Xencor Quarterly |
| 2022-11-07 | 10Q | XNCR/Xencor Quarterly |
| 2022-08-03 | 10Q | XNCR/Xencor Quarterly |
Receive XNCR News And Ratings
See the #1 stock for the next 7 days that we like better than XNCR
XNCR Financial Statistics
Sales & Book Value
| Annual Sales: | $110.5M |
|---|---|
| Cash Flow: | $-52.5M |
| Price / Cash Flow: | 37.37 |
| Annual Sales: | $9.64 |
| Price / Book: | 1.17 |
Profitability
| EPS (TTM): | -3.63000 |
|---|---|
| Net Income (TTM): | $-232.6M |
| Gross Margin: | $0 |
| Return on Equity: | -35.99% |
| Return on Assets: | -25.22% |
Xencor Earnings Forecast
Key Xencor Financial Ratios
-
The Gross Profit Margin over the past 4 years for XNCR is 0.00%.
-
The Selling, General & Administrative Expenses for XNCR have been equal to 55.40% of Gross Profit Margin.
-
The Research & Development expenses have been 206.06% of Revenue.
-
The Net Earning history of XNCR is -210.53% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 6 years.
Xencor Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | XNCR |
| CUSIP: | 98401F |
| Website: | xencor.com |
Debt
| Debt-to-Equity Ratio: | 0.24 |
|---|---|
| Current Ratio: | 6.61 |
| Quick Ratio: | 6.39 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |